These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23585363)

  • 21. Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis.
    Martínez F; Ramírez I; Pérez-Campos E; Latorre K; Lete I
    Eur J Contracept Reprod Health Care; 2012 Feb; 17(1):7-29. PubMed ID: 22239262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cardiovascular risks of combined oral contraceptives - beyond the French controversy].
    Gronier H; Robin G
    Gynecol Obstet Fertil; 2014 Mar; 42(3):174-81. PubMed ID: 24582295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined hormonal contraception and the risk of venous thromboembolism: a guideline.
    ;
    Fertil Steril; 2017 Jan; 107(1):43-51. PubMed ID: 27793376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of recurrent venous thromboembolism on progestin-only contraception: a cohort study.
    Le Moigne E; Tromeur C; Delluc A; Gouillou M; Alavi Z; Lacut K; Mottier D; Le Gal G
    Haematologica; 2016 Jan; 101(1):e12-4. PubMed ID: 26452982
    [No Abstract]   [Full Text] [Related]  

  • 25. Query about Faculty updated UKMEC.
    Lee DJ
    J Fam Plann Reprod Health Care; 2010 Jul; 36(3):181; author reply 181. PubMed ID: 20659387
    [No Abstract]   [Full Text] [Related]  

  • 26. Oral contraceptives and venous thromboembolism consensus opinion from an international workshop held in Berlin, Germany in December 2009.
    Reid RL; Westhoff C; Mansour D; de Vries C; Verhaeghe J; Boschitsch E; Gompel A; Birkhäuser M; Krepelka P; Dulicek P; Iversen OE; Khamoshina M; Dezman LV; Fruzzetti F; Szarewski A; Wilken-Jensen C; Seidman D; Kaaja R; Shapiro S
    J Fam Plann Reprod Health Care; 2010 Jul; 36(3):117-22. PubMed ID: 20659363
    [No Abstract]   [Full Text] [Related]  

  • 27. [Selected aspects of oral contraception side effects].
    Wolski H
    Ginekol Pol; 2014 Dec; 85(12):944-9. PubMed ID: 25669065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hormonal contraception, thrombosis and age.
    Lidegaard Ø
    Expert Opin Drug Saf; 2014 Oct; 13(10):1353-60. PubMed ID: 25227335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Which contraception for women with increased risk of venous thromboembolism?].
    Julen O; Dubuisson JB; Lourenço AG
    Rev Med Suisse; 2011 Feb; 7(281):351-4, 356. PubMed ID: 21416714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progestin-only contraception and venous thromboembolism.
    Blanco-Molina MA; Lozano M; Cano A; Cristobal I; Pallardo LP; Lete I
    Thromb Res; 2012 May; 129(5):e257-62. PubMed ID: 22425318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Venous thromboembolism and oral contraception].
    Veljković M; Popovć J
    Med Pregl; 2010; 63(5-6):376-9. PubMed ID: 21186550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thromboembolic events in women exposed to hormonal contraception or cyproterone acetate in 2012: a cross-sectional observational study in 30 French public hospitals.
    Gourbil M; Grandvuillemin A; Beyens MN; Massy N; Gras V; D'Amico A; Miremont-Salamé G; Petitpain N;
    Drug Saf; 2014 Apr; 37(4):269-82. PubMed ID: 24634164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined hormonal contraception and venous thromboembolism.
    Martínez F; Avecilla A
    Eur J Contracept Reprod Health Care; 2007 Jun; 12(2):97-106. PubMed ID: 17559006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel?
    Meurer LN; Slawson JG
    J Fam Pract; 2001 Feb; 50(2):108. PubMed ID: 11219554
    [No Abstract]   [Full Text] [Related]  

  • 35. The risk of thromboembolism and use of combined oral contraceptives: a comment.
    Birkhäuser M; Böttcher B; Germeyer A; Hadji P; Imthurn B; Mueck AO; Neulen J; Stute P; Thaler CJ; Wiegratz I; Wildt L
    BJOG; 2023 Jun; 130(7):844-845. PubMed ID: 36890428
    [No Abstract]   [Full Text] [Related]  

  • 36. [Suspension of Diane35 and its generics: an over-reaction by the French National Medicines Agency (ANSM) unfounded in the light of proven or accepted medical knowledge].
    Debarre JM
    Ann Dermatol Venereol; 2013; 140(6-7):474-8. PubMed ID: 23773753
    [No Abstract]   [Full Text] [Related]  

  • 37. Contraception, venous thrombosis and biological plausability.
    Rott H
    Minerva Med; 2013 Apr; 104(2):161-7. PubMed ID: 23514992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyproterone acetate with ethinylestradiol as a risk factor for venous thromboembolism: an epidemiological evaluation.
    Pini M
    J Obstet Gynaecol Can; 2004 Jul; 26(7):625; author reply 626. PubMed ID: 15329967
    [No Abstract]   [Full Text] [Related]  

  • 39. Risk of venous thromboembolism among users of oral contraceptives: a review of two recently published studies.
    Shapiro S; Dinger J
    J Fam Plann Reprod Health Care; 2010 Jan; 36(1):33-8. PubMed ID: 20067670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral oestrogen-progestagen contraceptives, menopausal treatment, and cancer.
    Shapiro S
    Lancet Oncol; 2005 Oct; 6(10):736; author reply 737. PubMed ID: 16198976
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.